ACCEL Lite: Primary PCI in Patients With Active Cancer Presenting With STEMI

Feb 17, 2021   |  Alison Bailey, MD, FACC; Ana Barac, MD, PhD, FACC; Sun Moon Kim, MD , FACC; Mamas A. Mamas, DPhil, MA, MB BCh

Podcast

Font Size
A
A
A

Patients with cancer presenting with a heart attack are less likely to receive invasive treatment because of perceived risks and poor outcomes. In this interview, Mamas A. Mamas, MA, DPhil, BMBCh; Ana Barac, MD, PhD, FACC; and Sun Moon Kim, MD, discuss a current study showing that patients with cancer admitted with a heart attack receiving invasive treatment gain as much benefit as patients without cancer.

Like what you hear? ACCEL Subscribers enjoy 20+ insider interviews like these every month, with CME/MOC credit and other exclusive benefits. Subscribe today for more, and check out what's new at www.acc.org/ACCEL.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Keywords: ACCELLite, Cardio-oncology, Cardiotoxicity, Myocardial Infarction, ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention


< Back to Listings